ArticleFarmaceuticos comunitarios2023
[Strategy to optimize patient safety in the community pharmacy dispensing service. Proposed checklists].
Article in Farmaceuticos comunitarios, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Dispensing is the most requested and important service within the tasks performed by the pharmacist, in his day-to-day work, in the community pharmacy. The aim of dispensing is to guarantee the patient's access to the medicine in an adequate and controlled manner. During that process, the community pharmacist has the obligation, as a healthcare professional, to actively participate in a committed manner in the detection of possible medication or medication-related errors.SEFAC´s patient safety group has developed, as the beginning of a series of future projects, checklists and best guidelines for medicines formulated as transdermal patches, modified release forms or orodispersible tablets. The aim of this initiative is to minimize as far as possible, by means of a prior interview with the patient and the use of these tools, any errors or problems that might arise with these drugs, thereby ensuring patient safety.A pilot project is expected to begin throughout 2023 in community pharmacies that collaborate with SEFAC's patient safety group. Therefore, they will be able to collect and report the results obtained.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.